TickerFacts.

A business in context

MCRB research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-15 · 0001193125-26-355734

  2. 4 · Ownership change

    Report date 2026-08-15 · 0001193125-26-355722

  3. 4 · Ownership change

    Report date 2026-08-15 · 0001193125-26-355718

  4. 4 · Ownership change

    Report date 2026-08-15 · 0001193125-26-355712

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-334174

  6. 8-K · Current report

    Report date 2026-08-05 · 0001193125-26-333820 · Items 2.02,9.01

  7. 8-K · Current report

    Report date 2026-07-31 · 0001193125-26-332742 · Items 1.01,1.02,9.01

  8. 4 · Ownership change

    Report date 2026-07-08 · 0001193125-26-300927

  9. 4 · Ownership change

    Report date 2026-07-08 · 0001193125-26-300926

  10. 4 · Ownership change

    Report date 2026-07-08 · 0001193125-26-300925

  11. 4 · Ownership change

    Report date 2026-07-08 · 0001193125-26-300924

  12. 8-K · Current report

    Report date 2026-07-08 · 0001193125-26-298525 · Items 5.02,5.07,9.01

  13. 8-K · Current report

    Report date 2026-07-08 · 0001193125-26-298005 · Items 7.01,8.01,9.01

  14. 8-K · Current report

    Report date 2026-06-02 · 0001193125-26-258366 · Items 1.01,7.01,9.01

  15. 8-K · Current report

    Report date 2026-05-30 · 0001193125-26-251548 · Items 5.02

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-205434

  17. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-205009 · Items 2.02,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-06-09 · 0001193125-26-182036

  19. 8-K · Current report

    Report date 2026-03-16 · 0001193125-26-108482 · Items 8.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-103276

  21. 8-K · Current report

    Report date 2026-03-12 · 0001193125-26-103034 · Items 2.02,7.01,9.01

  22. 8-K · Current report

    Report date 2026-02-27 · 0001193125-26-085368 · Items 5.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-266011

  24. 8-K · Current report

    Report date 2025-11-05 · 0001193125-25-265708 · Items 2.02,7.01,9.01

  25. 8-K · Current report

    Report date 2025-09-23 · 0001193125-25-230118 · Items 8.01

  26. 8-K · Current report

    Report date 2025-08-06 · 0001193125-25-173985 · Items 2.02,7.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-103611

  28. 8-K · Current report

    Report date 2025-07-17 · 0001193125-25-162552 · Items 5.02

  29. 8-K · Current report

    Report date 2025-05-07 · 0001193125-25-114430 · Items 2.02,7.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-065173

  31. 8-K · Current report

    Report date 2025-04-21 · 0001193125-25-089189 · Items 5.03,9.01

  32. 8-K · Current report

    Report date 2025-04-10 · 0001193125-25-080185 · Items 5.02,5.07,8.01,9.01

  33. 8-K · Current report

    Report date 2025-03-13 · 0001193125-25-053473 · Items 2.02,7.01,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-03-13 · 0000950170-25-038441

  35. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-038427

  36. 8-K · Current report

    Report date 2025-02-22 · 0001193125-25-039256 · Items 5.02

  37. 8-K · Current report

    Report date 2025-02-04 · 0001193125-25-021345 · Items 5.02

  38. 8-K · Current report

    Report date 2025-01-13 · 0001193125-25-005011 · Items 7.01,9.01

  39. 8-K · Current report

    Report date 2025-01-09 · 0001193125-25-004062 · Items 2.02,8.01,9.01

  40. 8-K · Current report

    Report date 2024-11-07 · 0001193125-24-256654 · Items 2.02,3.01,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 4 transaction rows4SGrant / award: 15 transaction rows15AExercise / conversion: 12 transaction rows12MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

31 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-17
2026-08-18
Brady KellyS · Sale
Disposed
Common Stock64.04.55
2026-08-17
2026-08-18
Shaff Eric D.S · Sale
Disposed
Common Stock263.04.55
2026-08-17
2026-08-18
Henn Matthew RS · Sale
Disposed
Common Stock81.04.55
2026-08-17
2026-08-18
DesRosier ThomasS · Sale
Disposed
Common Stock82.04.55
2026-08-15
2026-08-18
Brady KellyM · Exercise / conversion
Acquired
Common Stock181.0n/a
2026-08-15
2026-08-18
Brady KellyM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
90.00.0
2026-08-15
2026-08-18
Brady KellyM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
91.00.0
2026-08-15
2026-08-18
Shaff Eric D.M · Exercise / conversion
Acquired
Common Stock722.0n/a
2026-08-15
2026-08-18
Shaff Eric D.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
390.00.0
2026-08-15
2026-08-18
Shaff Eric D.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
332.00.0
2026-08-15
2026-08-18
Henn Matthew RM · Exercise / conversion
Acquired
Common Stock238.0n/a
2026-08-15
2026-08-18
Henn Matthew RM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
140.00.0
2026-08-15
2026-08-18
Henn Matthew RM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
98.00.0
2026-08-15
2026-08-18
DesRosier ThomasM · Exercise / conversion
Acquired
Common Stock245.0n/a
2026-08-15
2026-08-18
DesRosier ThomasM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
112.00.0
2026-08-15
2026-08-18
DesRosier ThomasM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
133.00.0
2026-07-08
2026-07-10
Graves KurtA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
Rosiello Robert L.A · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
Kender Richard NA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
50000.00.0
2026-07-08
2026-07-10
Berenson StephenA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
Henn Matthew RA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
25000.00.0
2026-07-08
2026-07-10
Thorell MarellaA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
7500.00.0
2026-07-08
2026-07-10
Fraser ClaireA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
Dere Willard HA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
DesRosier ThomasA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
7500.00.0
2026-07-08
2026-07-10
Ausiello Dennis AA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
Shaff Eric D.A · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
6500.00.0
2026-07-08
2026-07-10
Brady KellyA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
18750.00.0
2026-07-01
2026-07-02
Berenson StephenA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
7508.00.0
2026-07-01
2026-07-02
Rosiello Robert L.A · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
7508.00.0
2026-07-01
2026-07-02
Ausiello Dennis AA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
7508.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001609809Seres Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • Seres Therapeutics, Inc. · former SEC name · 2015-01-09 to 2026-08-21
  • Seres Health, Inc. · former SEC name · 2014-06-09 to 2015-05-14

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$0$0
2022-12-31$7.13M$8.21M
2021-12-31$144.93M$180.18M
2020-12-31$33.22M$43.24M
2019-12-31$34.51M$45.47M
2018-12-31$28.27M$37.93M
2017-12-31$32.10M$44.12M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗